These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 21251937)
21. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716 [TBL] [Abstract][Full Text] [Related]
22. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552 [TBL] [Abstract][Full Text] [Related]
23. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway. Li A; Wang J; Wu M; Zhang X; Zhang H Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792 [TBL] [Abstract][Full Text] [Related]
24. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009 [TBL] [Abstract][Full Text] [Related]
25. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats. Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774 [TBL] [Abstract][Full Text] [Related]
26. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases. Shaker ME; Ghani A; Shiha GE; Ibrahim TM; Mehal WZ Biochim Biophys Acta; 2013 Aug; 1833(8):1992-2003. PubMed ID: 23499874 [TBL] [Abstract][Full Text] [Related]
27. Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence. Jin H; Lian N; Zhang F; Chen L; Chen Q; Lu C; Bian M; Shao J; Wu L; Zheng S Cell Death Dis; 2016 Apr; 7(4):e2189. PubMed ID: 27077805 [TBL] [Abstract][Full Text] [Related]
28. Thymosin β4 suppresses CCl Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714 [TBL] [Abstract][Full Text] [Related]
29. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Mormone E; Lu Y; Ge X; Fiel MI; Nieto N Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190 [TBL] [Abstract][Full Text] [Related]
30. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. Zhang F; Zhang Z; Chen L; Kong D; Zhang X; Lu C; Lu Y; Zheng S J Cell Mol Med; 2014 Jul; 18(7):1392-406. PubMed ID: 24779927 [TBL] [Abstract][Full Text] [Related]
31. Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro. Zhang F; Kong DS; Zhang ZL; Lei N; Zhu XJ; Zhang XP; Chen L; Lu Y; Zheng SZ Apoptosis; 2013 Feb; 18(2):135-49. PubMed ID: 23247439 [TBL] [Abstract][Full Text] [Related]
32. Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice. Rampa DR; Feng H; Allur-Subramaniyan S; Shim K; Pekcec A; Lee D; Doods H; Wu D J Transl Med; 2022 Dec; 20(1):590. PubMed ID: 36514072 [TBL] [Abstract][Full Text] [Related]
33. The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. Nabil A; Uto K; Zahran F; Soliman R; Hassan AA; Elshemy MM; Ali IS; Ebara M; Shiha G Biomed Res Int; 2021; 2021():6678913. PubMed ID: 33855079 [TBL] [Abstract][Full Text] [Related]
34. Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells. Ma ZJ; Yue SS; Qin BY; Hu YT; Peng AK; Wang QY; Qi R Biochem Biophys Res Commun; 2024 Nov; 734():150732. PubMed ID: 39340924 [TBL] [Abstract][Full Text] [Related]
35. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of the PPARγ agonist, GW570, in liver fibrosis. Yang L; Stimpson SA; Chen L; Wallace Harrington W; Rockey DC Inflamm Res; 2010 Dec; 59(12):1061-71. PubMed ID: 20585829 [TBL] [Abstract][Full Text] [Related]
38. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857 [TBL] [Abstract][Full Text] [Related]
39. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis. Tao YY; Yan XC; Zhou T; Shen L; Liu ZL; Liu CH BMC Complement Altern Med; 2014 Nov; 14():449. PubMed ID: 25407538 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]